Alembic Pharmaceuticals Limited recalls Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Li…
- Recall date
- December 16, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0248-2026
- FDA classification
- Class III
- Brand / firm
- Alembic Pharmaceuticals Limited
- Sold / distributed
- US Nationwide and PR.
Why it was recalled
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
Get recall alerts
Free email alert whenever Alembic Pharmaceuticals Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Alembic Pharmaceuticals Limited